Search Results 2301-2310 of 14752 for anti-TNF drugs

  1. Selpercatinib (Oral Route) Proper Use - Mayo Clinic

    Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...

  2. Testosterone (Intramuscular Route, Subcutaneous Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your progress at regular visits to make sure ...

  3. Japanese Encephalitis Virus Vaccine (Intramuscular Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Publications - Michael J. Link, M.D. - Mayo Clinic

    Safety of the immediate use of nonsteroidal anti-inflammatory drugs after adult craniotomy for tumor. J Neurosurg. 2024 Jul 1; 141 (1):117-122 Epub 2024 Feb ...

  5. Neill R. Graff-Radford, M.D. - Mayo Clinic Faculty Profiles

    He is also studying normal pressure hydrocephalus to find those patients with good outcomes from treatment with shunt surgery; working to find a blood test that ...

  6. Emtricitabine And Tenofovir Alafenamide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Enfuvirtide (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Enfuvirtide injection is used in combination with other antiviral medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes ...

  8. Trastuzumab-Anns (Intravenous Route) Proper Use - Mayo Clinic

    Missed Dose. This medicine needs to be given on a fixed schedule. If you miss a dose, call your doctor, home health caregiver, or treatment clinic ...

  9. Tesevatinib in Subjects With ADPKD - Mayo Clinic

    By condition, treatment or drug ... anti-estrogens, or ovarian suppression. Women of ... Subject is taking any medication known to inhibit the CYP3A4 isozyme or any ...

  10. Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients with Advanced Cancers - Mayo Clinic

    Tumors that are relapsed or refractory to at least 1 prior anti-cancer systemic therapy and for which no standard therapy exists; Expansion cohort only ...